ACCP guidelines classification scheme: Difference between revisions
Jump to navigation
Jump to search
Created page with "{{SI}} {{CMG}}; {{AOEIC}} {{LG}} ==Overview== The '''Grading scheme''' is used to indicate whether a therapy is recommended or not according to the balance among benefits, ri..." |
m Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +) |
||
Line 22: | Line 22: | ||
{{reflist|2}} | {{reflist|2}} | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} |
Revision as of 19:10, 8 August 2012
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Lakshmi Gopalakrishnan, M.B.B.S. [2]
Overview
The Grading scheme is used to indicate whether a therapy is recommended or not according to the balance among benefits, risks, burdens, and possibly cost, and the degree of confidence in estimates of benefits, risks, and burdens.[1]
Grading Scheme Classification
- Grade 1: Strong recommendation
- Grade 2: Weak recommendation
Level of Evidence
The level of evidence is classified according to the factors that include the study design, the consistency of the results, and the directness of the evidence.[1]
- Grade A: High
- Grade B: Moderate
- Grade C: Low
Resources
Grading Strength of Recommendations and Quality of Evidence in Clinical Guidelines[1]
References
- ↑ 1.0 1.1 1.2 Guyatt G, Gutterman D, Baumann MH, Addrizzo-Harris D, Hylek EM, Phillips B, Raskob G, Lewis SZ, Schünemann H (2006). "Grading strength of recommendations and quality of evidence in clinical guidelines: report from an american college of chest physicians task force". Chest. 129 (1): 174–81. doi:10.1378/chest.129.1.174. PMID 16424429. Retrieved 2012-04-10. Unknown parameter
|month=
ignored (help)